Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Shares Outstanding (Weighted Average) (2017 - 2025)

Selectis Health's Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $3.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $3.1 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $3.1 million (changed 0.0% YoY), and the annual figure for FY2025 was $3.1 million, changed 0.0%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $3.1 million at Selectis Health, roughly flat from $3.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $3.1 million in Q1 2024 to a low of $2.7 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $3.1 million (2023), against an average of $3.0 million.
  • The sharpest move saw Shares Outstanding (Weighted Average) tumbled 90.21% in 2021, then rose 13.63% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $2.8 million in 2021, then rose by 10.33% to $3.1 million in 2022, then grew by 0.02% to $3.1 million in 2023, then increased by 0.41% to $3.1 million in 2024, then changed by 0.0% to $3.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $3.1 million, $3.1 million, and $3.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.